The Cell & Gene Meeting on the Mesa, 2025 in Phoenix, Arizona
The Cell & Gene Meeting on the Mesa, 2025 in Phoenix, Arizona
We are thrilled to be participating in the 2025 Meet Taipei Startup Festival, showcasing how strategic Patent Innovation is accelerating the future of medicine! At the heart of our exhibit is our groundbreaking xenogeneic cell cancer immunotherapy. We're leveraging the body's natural immune response to non-self cells to develop a powerful, constructive new treatment modality for difficult-to-treat cancers and other intractable diseases. This proprietary platform, protected by our growing portfolio of global patents, demonstrates our commitment to transforming patient outcomes. We believe the future of cellular medicine is here—and it's driven by IP. Join us at the NEXT IS NOW: Patent Driven, Global View special zone to explore how our innovations are moving from lab to clinic. Let's build a healthier world, together.
We are thrilled to be participating in the 2025 Meet Taipei Startup Festival, showcasing how strategic Patent Innovation is accelerating the future of medicine! At the heart of our exhibit is our groundbreaking xenogeneic cell cancer immunotherapy. We're leveraging the body's natural immune response to non-self cells to develop a powerful, constructive new treatment modality for difficult-to-treat cancers and other intractable diseases. This proprietary platform, protected by our growing portfolio of global patents, demonstrates our commitment to transforming patient outcomes. We believe the future of cellular medicine is here—and it's driven by IP. Join us at the NEXT IS NOW: Patent Driven, Global View special zone to explore how our innovations are moving from lab to clinic. Let's build a healthier world, together.
Immunotherapy, cell therapy
It takes exceptional teamwork and collaboration to prepare for our first clinical trial. Thank you to PharmaSols remarkable clinical trial plant work. It was great meeting up with PharmaSols in Auckland on 1 March, 2023. PharmaSols is a company provide helps global pharma and biotech leverage the benefits of running clinical trials in Australia and New Zealand. And they have been delivering successful clinical trials for over 20 years
Immunotherapy, cell therapy
March 2, 2023 NZeno, a New Zealand Company Agree to support eXCELL We are very excited to announce that NZeno, a New Zealand biotech company is in the initial agreement to support eXCELL with the DSPF PIG tissues for xenogeneic cell product. The collaboration meeting was held with NZeno CEO, Dr. Tan and CSO, Dr. Garkavenko in Auckland on March 2, 2023. NZeno is a company that develops medical research on Auckland Island pigs. The high health status of New Zealand’s pigs has made it possible for this country to be a leader in the development of xenogeneic cell therapy with cells from pig tissues
2025 Biotechnology Industry Development Strategy Forum
eXCELL Biomedicine participate in 2025 Taiwan Biotechnology Industry Development Strategy Forum
2023 BIO International Convention
eXCELL Biotherapeutic participates in 2023 BIO International Convention
The BIO International Convention is the world’s largest gathering of the biotechnology industry along with industry-leading investor and partnering meetings held around the world. eXCELL Bioterapeutics Inc. Participates in BIO International Convention 2023 to showcase the company’s global innovative research and development accomplishments at booth #743 at the Boston Convention & Exhibition Center.
eXCELL Biotech is Paving the Way for Transformative Cancer Treatment at Meet Taipei 2025
eXCELL Biotech is Paving the Way for Transformative Cancer Treatment at Meet Taipei 2025
The Cell & Gene Meeting on the Mesa, 2025 in Phoenix, Arizona
The Cell & Gene Meeting on the Mesa, 2025 in Phoenix, Arizona